Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.

Once a cut is made, it is a multistep, imperfect process of cellular DNA repair. CRISPR can be used to make other types of edits too, such as increasing or decreasing the effects of a gene ...

CRISPR is a powerful gene-editing tool that holds enormous potential for treating genetic diseases by allowing scientists to ...

Escobar uses CRISPR-Cas9, which is often described as “gene-editing scissors” and for which a Nobel Prize was awarded in 2020. The molecular scissors are guided to a precise location along a DNA ...

To fix the dysferlin mutation, Escobar uses CRISPR-Cas9, which is often described ... forcing the cell to repair the DNA. The aim is for the mutation to be corrected during the repair process ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing medicines targeting metalloenzymes, announced today that it will present preclinical data on its ...

The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage ...

Canada’s national nuclear laboratories announces new projects with leading Canadian biopharmaceutical companies through collaborative research program ...

Detailed price information for Repare Therapeutics Inc (RPTX-Q) from The Globe and Mail including charting and trades.